三鑫医疗: 关于本次向不特定对象发行可转换公司债券摊薄即期回报、采取填补措施及相关主体承诺的公告

Core Viewpoint - The company plans to issue convertible bonds to unspecified investors, which may dilute immediate returns for existing shareholders, and has outlined measures to mitigate this dilution [1][4][5]. Financial Impact Analysis - The issuance of convertible bonds is expected to lead to a dilution of earnings per share (EPS) in the short term, with projections showing a decrease in diluted EPS from 0.44 to 0.39 under certain profit growth scenarios [2][3]. - The company has simulated financial impacts under three scenarios of net profit growth: no growth, 10% growth, and 20% growth, with corresponding EPS adjustments [3]. Necessity and Reasonableness of the Issuance - The funds raised will be used for projects that enhance the company's core competitiveness and sustainable development, including the expansion of production capacity for blood purification products [5][6]. - Specific projects include the expansion of blood dialysis membrane production and the establishment of a new production line for blood purification equipment [5][6]. Relationship with Existing Business - The projects funded by the issuance are closely related to the company's core business of blood purification, which is currently operating at near full capacity [5][6]. - The company aims to alleviate operational funding pressures and support future business development through these investments [5][6]. Measures to Mitigate Dilution - The company plans to enhance its governance structure and internal management to improve operational efficiency and protect shareholder interests [10][11]. - A commitment to improve the efficiency of fund usage and ensure compliance with regulations regarding the management of raised funds has been established [11][12]. Commitment from Major Stakeholders - The controlling shareholders and management have made commitments to ensure the effectiveness of measures to mitigate the dilution of immediate returns [12][13]. - These commitments include not interfering with company operations and ensuring that the interests of shareholders, especially minority investors, are protected [12][13].